Entering text into the input field will update the search result below

Hillrom inks agreement to buy Bardy Diagnostics for $375M in cash

  • Hillrom (NYSE:HRC) enters an agreement to acquire Bardy Diagnostics, an innovator in digital health and a provider of ambulatory cardiac monitoring technologies.
  • As per the terms, Hillrom will purchase BardyDx for a cash consideration of $375M and future potential payments based on

Recommended For You

More Trending News

About BAX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BAX--
Baxter International Inc.